PepsiCo will invest $64 million to expand its beverage concentrates plant in Uruguay’s Colonia Free Trade Zone by more than 6,000 square meters to expand its zero-sugar offerings.
The expansion would include upgraded production rooms, an extension of water waste treatment, and the plant’s footprint to manage its manufacturing facilities.
The Colonia plant is one of two that PepsiCo operates in Uruguay and employs around 350 people.
The plant plays a significant part in formulating PepsiCo’s beverages, such as Pepsi, 7Up, Mirinda, and Gatorade.
The second plant in Montevideo is a key site for the company’s foods business for over 60 years.
PepsiCo earlier announced that it would invest £1 billion to open another plant in Poland, which would be it's fifth in Poland.
The plant would create 450 new jobs and produce for over 20 European countries. Construction is set for completion by 2025, with plans to become fully carbon-neutral by 2035.


Asian Currencies Stay Rangebound as Yen Firms on Intervention Talk
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Nikkei 225 Hits Record High Above 56,000 After Japan Election Boosts Market Confidence
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Lee Seung-heon Signals Caution on Rate Hikes, Supports Higher Property Taxes to Cool Korea’s Housing Market
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
Asian Markets Surge as Japan Election, Fed Rate Cut Bets, and Tech Rally Lift Global Sentiment 



